tbc-11251 has been researched along with Chronic Kidney Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eräranta, A; Lakkisto, P; Mustonen, J; Niemelä, O; Paavonen, T; Pörsti, I; Tikkanen, I; Törmänen, S | 1 |
| Brown, KE; Dhaun, N; Goddard, J; Kennedy, ED; Kimmitt, RA; MacIntyre, IM; Melville, V; Moorhouse, R; Oosthuyzen, W; Webb, DJ | 1 |
| Chariyavilaskul, P; Corder, R; Dhaun, N; Goddard, J; Kimmitt, RA; MacIntyre, IM; Webb, DJ; Wood, EG; Yuzugulen, J | 1 |
| Bellamy, CO; Dhaun, N; Kluth, DC; MacIntyre, IM | 1 |
| Dhaun, N; Goddard, J; MacDougall, M; Melville, V; Towler, JD; Webb, DJ | 1 |
| Kohan, DE; Pollock, DM | 1 |
| Blackwell, S; Dhaun, N; Goddard, J; Johnston, NR; Melville, V; Talwar, DK; Webb, DJ | 1 |
1 review(s) available for tbc-11251 and Chronic Kidney Diseases
| Article | Year |
|---|---|
Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.
Topics: Animals; Clinical Trials as Topic; Diabetic Nephropathies; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Humans; Isoxazoles; Kidney Failure, Chronic; Pyridines; Pyrimidines; Renal Dialysis; Renal Insufficiency, Chronic; Thiophenes; Treatment Outcome | 2013 |
3 trial(s) available for tbc-11251 and Chronic Kidney Diseases
| Article | Year |
|---|---|
Plasma pro-endothelin-1 peptide concentrations rise in chronic kidney disease and following selective endothelin A receptor antagonism.
Topics: Adult; Biomarkers; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Endothelin A Receptor Antagonists; Endothelin-1; Female; Humans; Isoxazoles; Male; Middle Aged; Nifedipine; Protein Precursors; Proteinuria; Receptor, Endothelin A; Renal Insufficiency, Chronic; Scotland; Thiophenes; Time Factors; Treatment Outcome; Up-Regulation; Vascular Stiffness | 2015 |
What is the best method of proteinuria measurement in clinical trials of endothelin receptor antagonists?
Topics: Albuminuria; Analysis of Variance; Creatinine; Double-Blind Method; Drug Monitoring; Endothelin Receptor Antagonists; Humans; Isoxazoles; Proteinuria; Renal Insufficiency, Chronic; Reproducibility of Results; Thiophenes | 2012 |
Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD.
Topics: Adult; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cross-Over Studies; Double-Blind Method; Endothelin Receptor Antagonists; Endothelin-1; Female; Humans; Isoxazoles; Male; Middle Aged; Nifedipine; Proteinuria; Pulse Wave Analysis; Renal Insufficiency, Chronic; Thiophenes; Vascular Stiffness; Vasodilator Agents | 2013 |
3 other study(ies) available for tbc-11251 and Chronic Kidney Diseases
| Article | Year |
|---|---|
Endothelin A receptor blocker and calcimimetic in the adenine rat model of chronic renal insufficiency.
Topics: Adenine; Animals; Calcimimetic Agents; Cinacalcet; Disease Models, Animal; Endothelin A Receptor Antagonists; Isoxazoles; Male; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Thiophenes | 2017 |
Diurnal variation in blood pressure and arterial stiffness in chronic kidney disease: the role of endothelin-1.
Topics: Adult; Blood Pressure; Case-Control Studies; Circadian Rhythm; Endothelin Receptor Antagonists; Endothelin-1; Female; Humans; Isoxazoles; Male; Middle Aged; Renal Insufficiency, Chronic; Thiophenes; Vascular Stiffness | 2014 |
Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney.
Topics: Amides; Antihypertensive Agents; Atrophy; Biomarkers; Biopsy; Endothelin Receptor Antagonists; Female; Fibrosis; Fumarates; Humans; Hypertension, Renal; Isoxazoles; Kidney; Middle Aged; Proteinuria; Pulmonary Fibrosis; Renal Insufficiency, Chronic; Renin; Scleroderma, Systemic; Thiophenes; Treatment Outcome | 2009 |